Introduction {#sec1-1}
============

Hereditary sensory and autonomic neuropathy (HSAN) is a genetic disorder of sensory and autonomic dysfunction. Till date, eight types of HSAN have been described depending on the clinical phenotype and the underlying gene mutation.\[[@ref1][@ref2]\] We report a new variant of HSAN in two siblings (of Indian origin) with a novel mutation of *SCN11A* gene and a distinct clinical phenotype.

Case Report {#sec1-2}
===========

Two sisters (aged 6 and 3 years) born of a nonconsanguineous marriage presented with absence of pain sensation and sweating since birth along with redness over the body on heat exposure, recurrent febrile episodes, dry mouth, and decreased tears. The elder child complained of recurrent episodes of mild abdominal pain. History of celiac disease and hypothyroidism was present in the paternal cousin sister. There was no evidence of mental retardation, self-mutilating behavior, developmental delay, or history of recurrent infections. Superficial and deep pain sensations were absent over the entire body, while touch, temperature, pressure, and vibration sensations were normal. Tendon reflexes and muscle power in both the upper and lower limbs were normal. Erythema was present on the bilateral malar areas in both children \[[Figure 1a](#F1){ref-type="fig"}\]. On oral examination, overcrowded, dysplastic teeth, and malocclusion with dental caries were present \[[Figure 1b](#F1){ref-type="fig"}\]. Xerophthalmia was evident with positive Schirmer's test. Electromyography (EMG) and nerve conduction velocity (NCV) studies of both sisters showed impaired sympathetic skin responses from both the hands and feet, suggestive of small fiber neuropathy or autonomic dysfunction. Biopsies from the palms of both sisters showed sweat ducts but mostly absent secretory portion of eccrine glands. Intelligence quotient of both girls was normal. Anti-Ro and anti-La antibodies and transglutaminase antibodies were negative.

![(a) Marked erythema on malar area of the face, (b) dysplastic teeth with malocclusion and dental caries in proband 2](IJD-65-299-g001){#F1}

Based on the clinical features and preliminary investigations, the diagnosis of HSAN with idiopathic non-Sjögren Sicca Syndrome-like symptoms was considered. Targeted gene sequencing in elder sister detected a heterozygous missense variation (c.4064G\>G/T \[p. Cys1355Phe\]) in exon 25 of *SCN11A* (chromosome 3:38892235; C\>C/A; Depth: 41x) with autosomal dominant inheritance, resulting in substitution of phenylalanine for cysteine at codon 1355 (p.Cys1355Phe; ENST00000302328). Younger sibling and father also showed the same heterozygous missense variation in exon 25 of *SCN11A*. However, the father was asymptomatic with normal EMG and NCV studies. Genetic analysis of mother was normal. Parents were counseled to prevent both sisters from high-impact activities and extreme temperatures. Soft-sole footwear for the prevention of trophic changes, lubricant eye drops, and professional dental care were advised.

Discussion {#sec1-3}
==========

In 1993, Dyck provided a detailed classification of HSAN based on the clinical features.\[[@ref1]\] The classification has been modified subsequently based on causative genes and identification of new types. The types of HSAN with their clinical features, genetic defect, and mode of inheritance are described in [Table 1](#T1){ref-type="table"}. This heterogeneous group of disorders can arise through (i) congenital absence or a progressive degeneration of sensory and/or autonomic neurons (neuropathy) or (ii) altered function of voltage-gated sodium channels (Na~v~1.7 and Na~v~1.9) within normal sensory neurons (channelopathy).

###### 

Classification of HSAN based on age of onset, mode of inheritance, clinical presentation and their genetic background

  Types of HSAN                 Gene/locus and mode of Inheritance   Pathogenic defect                                                                                              Onset                      Impairment of sensation                                                                                                         Sweating                             Clinical characteristics
  ----------------------------- ------------------------------------ -------------------------------------------------------------------------------------------------------------- -------------------------- ------------------------------------------------------------------------------------------------------------------------------- ------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  I-A                           AD SPTLC1/9q22.31                    Serine C-palmitoyl transferase deficiency; formation of atypical and neurotoxic sphingolipid metabolites       Adolescence to adulthood   Loss of pain and temperature sensation, lancinating pain                                                                        Normal                               Hearing loss, loss of distal reflexes/distal muscle weakness, (no autonomic dysfunction)
  I-B                           AD SPTLC1/3p24-p22                   Serine Cpalmitoyl transferase deficiency; formation of atypical and neurotoxic sphingolipid metabolites        Adulthood                  Sensory loss, lancinating pain                                                                                                  Normal to mild distal hypohidrosis   Chronic cough, gastropharyngeal reflux, hearing loss, alacrima, impotence
  I-C                           AD SPTLC2/14q24.3                    Serine Cpalmitoyl transferase deficiency; formation of atypical and neurotoxic sphingolipid metabolites        Adulthood                  Loss of pain, lancinating pain, loss of temperature sensation in parts of the body, sensory loss in the upper and lower limbs   Normal                               Ulcerative mutilations, variable distal motor involvement, distal muscle weakness, osteomyelitis
  I-D                           AD ATL1/14q22.1                      Atlastin-1 Endoplasmic reticulum                                                                               Adulthood                  Distal sensory loss of the lower limbs                                                                                          Normal                               Ulcerative mutilations, trophic skin and nail changes, distal amyotrophy in the lower limbs
  I-E                           AD DNMT1/19p13.2                     DNA methyltransferase 1                                                                                        Adulthood                  Loss of all somatosensory modalities, lancinating pain                                                                          Normal                               Ulcerative mutilations, hearing loss, dementia
  I-F                           AD ATL3/11q13.1                      Atlastin3:Endoplasmic reticulum structure altered                                                              Adulthood                  Distal sensory loss of the lower limbs                                                                                          Normal                               No autonomic involvement, diminished tendon reflexes, painless ulceration of the feet
  II-A                          AR WNK1/12p13.33                     WNK (With No lysine (K)) protein; Transmembrane ionic transport, vesicles of trans --- golgi network           Childhood                  Loss of pain, temperature and touch sensation, no autonomic dysfunction                                                         Normal                               Self-mutilation behavior resulting in extensive orofacial injuries, weakness, acropathy
  II-B                          AR FAM134B/5p15.1                    Located in dorsal root ganglia, Golgi apparatus                                                                Childhood                  Impaired pain sensation                                                                                                         Hyperhidrosis                        Ulcerative mutilation of hands, feet, and orofacial structures, osteomyelitis, urge incontinence
  II-C                          AR KIF1A/2937.3                      KIF1A (kinesin family) reduction in synaptic vesicles in nerve terminals                                       Childhood to adolescence   Impaired position and vibration senses                                                                                          N/A                                  Ulcerative mutilation and orofacial injuries, absent deep tendon reflexes, minor distal weakness, distal numbness of the hands and feet
  II-D                          AR SCN9A/2q24.3                      Nav1.7.Reduced action potential firing in nociceptor neurons in DRG neurons                                    Infancy or adolescence     Loss of pain and temperature sensation, hypogeusia                                                                              Hypohidrosis                         Autonomic nervous dysfunction, hearing loss, hyposmia, bone dysplasia, orofacial self-mutilation injuries
  III                           AR IKBKAP/9q31.3                     (I-κB- kinase complex associated protein); affects neuronal polarity, differentiation and survival.            At birth/ Infancy          Loss of pain and temperature sensation                                                                                          Hyperhidrosis                        Profound autonomic dysfunction, vasomotor instability, absence of deep tendon reflexes, alacrima, impaired blood pressure regulation, failure to thrive, orofacial self-mutilation, absent fungiform papillae on the tongue, increased salivation, low caries index
  IV                            AR NTRK1/1q23.1                      Tyrosine kinase receptor I; affects signal transduction                                                        At birth/Infancy           Loss of pain and temperature sensation                                                                                          Hypohidrosis to anhidrosis           Self-mutilation with orofacial injuries, deep tendon reflexes usually intact, recurrent fever, corneal lesions, mental retardation, recurrent infections, skin hyperkeratosis and fissuring, generalized tonic-clonic seizures, emotional lability
  V                             AR NGFB/1p13.2                       Nerve growth factor beta (NGFB):Affects regeneration of damaged axons, sympathetic axon growth                 At birth/Infancy           Loss of pain and reduced thermal sensation, loss of deep pain perception                                                        Normal to hypohidrosis               Similar to HSAN IV but normal intelligence
  VI                            AR DST/6p12.1                        Dystonin: Cytoskeletal formation and vesicle transportation affected                                           At birth/Infancy           Loss of pain and temperature sensation                                                                                          N/A                                  Lack of psychomotor development, autonomic abnormalities, absence of deep tendon reflexes, feeding and respiratory difficulties, neonatal hypotonia, alacrima, blotching
  VII                           AD SCN11A/3p22.2                     Nav1.9, impaired action potential generation                                                                   At birth/Infancy           Loss of pain sensation                                                                                                          Hyperhidrosis                        Self-mutilation, painless fractures, delayed motor development, gastrointestinal dysfunction
  VIII                          AR PRDM12/9q34.12                    PR domain-containing protein 12; loss of the small myelinated Aδ fibers, alteration of unmyelinated C fibers   Onset in infancy           Reduced pain and temperature sensation                                                                                          Hypohidrosis                         Self-mutilation behavior with orofacial injuries, painless fractures, skin and bone infections, corneal injuries, no mental retardation
  HSN with spastic paraplegia   AR CCT5/5p15.2                       Actin and tubulin folding                                                                                      Early childhood            Loss of all somatosensory modalities                                                                                            Normal                               Mutilation, acropathy, septic paraplegia

The neuropathies are caused by a variety of genes affecting neurotrophic functions (neurotrophic receptor tyrosine kinase-1 and nerve growth factor), sphingolipid metabolism (*SPTLC1* and *SPTLC2*), structural integrity of the endoplasmic reticulum (*ATL1*) and Golgi apparatus (*FAM134B*), vesicular trafficking (*KIF1A*), and epigenetic regulator expressed in nociceptors (*PRDM12*).\[[@ref2][@ref3]\]

Voltage-gated sodium channels in cell membranes are essential for initiation and propagation of action potentials in neurons. Ten such channels (Na~v~1.1--1.9 and Na~v~2.x) which are encoded by genes *SCN1A-SCN5A and SCN7A-SCN11A* have been discovered till date. Defects in Na~v~1.7, Na~v~1.8, and Na~v~1.9 encoded by *SCN9A, SCN10A, and SCN11A,*, respectively, have been reported to cause pain disorders.\[[@ref4][@ref5][@ref6][@ref7][@ref8][@ref9][@ref10]\]

Na~v~1.9 is expressed in peripheral sensory, trigeminal and dorsal root ganglia, and enteric plexus. The main function of Na~v~1.9 is to transmit pain signals from the periphery to the central nervous system. It consists of a 260-kDa α-subunit and an auxiliary β-subunit. Each α-subunit consists of six α-helical transmembrane-spanning segments (S1--S6). S1--S4 segments form the voltage-sensing domain that controls voltage-dependent gating while S5--S6 segments form the pore domain which conducts selective sodium filtering.

*SCN11A* gene (chromosome 3), which encodes Na~v~1.9, has 26 exons that annotate 31 domains. Gain-of-function mutations in *SCN11A* have been reported to cause loss of pain sensation (HSAN VII) as well as the severe paroxysmal pain disorder (familial episodic pain syndrome 3).\[[@ref6][@ref7]\] These seemingly contradictory consequences of similar mutations is explained by the impact on resting membrane potential (RMP), wherein large depolarizations of RMP caused by some mutations are associated with hypoexcitability (insensitivity to pain, HSAN VII), whereas lesser degrees of membrane depolarization caused by other Na~v~1.9 mutations are associated with hyperexitability (familial episodic pain disorder).\[[@ref8]\]

Till date, HSAN VII has been reported to be caused by two heterozygous missense mutations in *SCN11A*; (1) c.2432T\>C (p.Leu811Pro) in exon 15 and (2) c.3904C\>T (p.Leu1302Phe) in exon 23.\[[@ref4][@ref9][@ref10]\] These gain-of-function mutations result in excess sodium influx, and subsequent cell depolarization at rest may cause progressive conduction block in other ion channels. Insufficient activation of calcium ion channels results in impaired neurotransmitter release at presynaptic nerve terminals resulting in nontransmission of pain signals to the spinal cord.\[[@ref4]\]

Apart from congenital sensitivity to pain, Type VII HSAN clinical phenotype comprises severe self-mutilation, multiple painless fractures, delayed motor development, and hyperhidrosis. None of these were present in the present cases. Possibly, the novel mutation in *SCN11A* might have caused a different structural alteration in the Na~v~1.9 channel resulting in hypohidrosis, alacrimia, lack of salivary secretion, a much lesser severity of sensory dysfunction, and lack of any developmental delay. Thus, we propose this hitherto undescribed phenotype of HSAN with non-Sjögren sicca syndrome-like symptoms (alacrimia and dry mouth) and a novel mutation (p. Cys1355Phe) of *SCN11A* to be a new type of HSAN, i.e., HSAN Type IX. Another notable feature in this family is the incomplete penetrance of the mutation with the father having virtually no symptoms despite carrying the same mutation.

This case report highlights the variability of phenotypes and penetrance in HSAN, variability of phenotype in *SCN11A* mutations, and also the importance of the genetic mutation in designating appropriate classification of HSAN.
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